Given the limitations that our obese and non-obese patient cohorts were small, and follow-up duration relatively short, our data suggest that epithelial CXCL1 expression and CXCR1-positive tumour stroma in obese patients may be associated with more aggressive disease features. Here, CXCL1 is linked to neoplasm.